RT Journal Article
SR Electronic
T1 Association of 25-OH Vitamin D Levels With In-Hospital Mortality: A cross-sectional, observational study of the MIMICIV database
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.05.24308492
DO 10.1101/2024.06.05.24308492
A1 Wang, Yaotang
A1 Lv, Weijing
A1 Yu, Haixia
YR 2024
UL http://medrxiv.org/content/early/2024/06/05/2024.06.05.24308492.abstract
AB The relationship between 25-OH Vitamin D3 and hospital death continues to be a topic of controversy. At present, the available evidence regarding the relationship between 25-OH Vitamin D and hospital death is inadequate. Therefore, we conducted a cross-sectional study involving 197 sepsis-3 participants from MIMIC-IV. Basic information, laboratory indicators, underlying Disease, therapeutic medications and tools, disease score were obtained from all participants. Serum 25-OH Vitamin D was collected on Intensive Care Unit (ICU) admission, and inpatient mortality were analyzed. The logistic regression, fitting curve and interaction effects were utilized to substantiate the correlation of serum 25-OH Vitamin D with inpatient mortality. Furthermore, interaction and subgroup analyses were evaluated for the consistency of these correlations. A total of 197 patients were included in the analysis, with an average age of 59.8 years and 43.1% male. The mean 25-OH vitamin D level in the cohort was 21 ng/mL. We observed no significant association between higher 25-OH vitamin D levels and increased inpatient mortality rates. The in-hospital mortality did not differ among patients vitamin D deficiency, insufficiency and sufficiency group (15.7% vs 17.4% vs 24.5%, p=0.417). A multivariable adjusted logistic regression model showed that vitamin D levels could not predict in-hospital mortality (OR 1.02 95% CI: 0.98∼1.05, p=0.342, Model 3). In conclusion, 25-OH vitamin D detected upon ICU admission was not associated with in-hospital mortality in patients with sepsis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://physionet.org/content/mimiciv/2.2/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe MIMIC data analyzed in the current study are publicly available.